Académique Documents
Professionnel Documents
Culture Documents
The Department of Infectious Diseases and Epidemiology with Course of Microbiology, Virology and Immunology
Active Immunization
Stimulates the hosts immune system to produce specific antibodies or cellular immune responses or both which would protect against or eliminate a disease.
Passive Immunization
A preparation of antibodies that neutralizes a pathogen and is administered before or around the time of known or potential exposure.
Vaccines
Provide an antigenic stimulus that does not cause disease but can produce long lasting, protective immunity
Quick amplification
Specific
Clearance of the pathogen after infection Intracellular pathogen with cell to cell transmission Cell mediated
Clearance of the pathogen before spreading Extra cellular pathogens or free intracellular pathogens Antibody mediated
Vaccine technologies
Live vaccines Recombinant vaccines
Killed vaccines Plasma derived vaccines Polysaccharide conjugates Peptide vaccines Subunit vaccines DNA vaccines Combination vaccines Examples polio, yellow fever RSV influenza, pertussis Hepatitis B Hib, Pneumo Malaria HIV candidates Influenza DPT
Passive (antibodies)
Inactivated
whole-agent
vaccines
use microbes that have been killed, usually by formalin or phenol. Inactivated virus vaccines used in humans include those against rabies (animals sometimes receive a live vaccine considered too hazardous for humans), influenza, and polio (the Salk poliovaccine). Inactivated bacterial vaccines include those for pneumococcal pneumonia and cholera. Several long-used inactivated vaccines that are being replaced for most uses by newer, more effective types are those for pertussis (whooping cough) and typhoid.
Toxoids, which
are inactivated toxins, are vaccines directed at the toxins produced by a pathogen. The tetanus and diphtheria toxoids have long been part of the standard childhood immunization series. They require a series of injections for full immunity, followed by boosters every 10 years. Many older adults have not received boosters; they are likely to have low levels of protection.
use only those antigenic fragments of a microorganism that best stimulate an immune response. Subunit vaccines that are produced by genetic modification techniques, meaning that other microbes are programmed to produce the desired antigenic fraction, are called recombinant vaccines. For example, the vaccine against the hepatitis B virus consists of a portion of the viral protein coat that is produced by a genetically modified yeast.
Subunit vaccines
Conjugated vaccines
Polysaccharide vaccines
Unique type of inactivated subunit vaccine composed of long chains of sugar molecules that make up the surface capsule of certain bacteria.
Available for Pneumococcal disease, meningococcal disease and Haemophilus influenzae type b
Combination vaccines
Examples influenza trivalent OPV, inactivated IPV DPT, DPT/Hib, etc. MMR, MMRV PnC/MnC only one needle at a visit may reduce number of visits reduces costs of administration geographic tailoring loss of immunogenicity due to competition technically more difficult to produce higher production costs higher evaluation costs
Advantages:
Disadvantages:
Correlates ?
Humoral component
Tetanus Dyphteria H. influenzae Influenza Measles Varicella (herpes zoster) Dengue S. pneumoniae
Cellular components
BCG HIV Herpes type 1&2 Shingles (herpes zoster) Influenza in elderly Varicella (herpes zoster) Measles
Description of immunity
Postinfection Postvaccine Active Passive Humoral Cellular Antibacterial Antiviruses Antitoxins Antifungal Specific Nonspecific Group specific, species specific, Type-specific
Staphylococcal toxoid
Content: this vaccine, in which contains inactivated, which help formalin (0,4%) and temperature (56C) exotoxin S.aureus. It is used for specific preventive and treatment of staphylococcal infections
What type of immunity (originally) is created in an organism after introduction?
APDT
Content: - dsorbed on the hydrate of oxide of aluminium mixed vaccine, consisting of the killed microorganisms the whooping-cough bacterias and toxoids diphtherial and tetanic. Used for plannad prophylaxis.
What type of immunity (originally) is created in an organism after introduction?
Adjuvant activity
Formation of a depot of antigen primarily at the site of application from which the antigen is released during a variable period
Increased uptake of antigen into APCs
Adjuvant activity
Facilitation of antigen transport, uptake and presentation by antigen-capturing and processing cells Repeated or prolonged release of antigen (depot effect) Signaling of receptors activating innate immune cells to release cytokines which upregulate co-stimulatory molecules Danger signals from stressed or damaged tissues activate APCs Signaling by recombinant cytokines or co-stimulatory molecules mimics classical adjuvant activity
Immunotherapy preformed Ab
Immune serum globulin (gammaglobulin) contains immunoglobulin extracted from the pooled blood of at least 1,000 human donors Treatment of choice for preventing measles, hepatitis A and replacing Ab in the immune deficient Lasts 2-3 months
Immunotherapy preformed Ab
Specific immune globulin- prepared from
convalescent patients in a hyperimmune state Contains high titer of specific Ab pertussis, tetanus, chickenpox, hepatitis B sera produced in horses are available for diphtheria, botulism, spider and snake bites act immediately and can protect patients for whom no other useful medication exists
Cell
Antianthracis gamma-globulin
Content: preparation contains
antitoxins. It is gammaglobulins fraction of serum of the hyperimmunized animals. There is the diminished amount of ballast matters in such preparation, that diminishes probability of development of by-reactions, above all things allergic substantially
by hyperimmunization of horse a diphtherial toxoid. Effective mean of specific therapy of diphtheria. At the use it should be remembered rules of introduction of heterogenic serum, to eliminate development of anaphylactic shock and serum illness.
Serum Sickness
This is a systemic form of hypersensitivity of immediate reaction. It appears 7 to 12 days following single injection of high concentration of foreign serum
37
IgE antibodies, produced in response to an antigen (heterogenic antibody), coat mast cells and basophils. When an antigen bridges the gap between two adjacent antibody molecules of the same specificity, the cell under goes degranulation and releases histamine and other mediators.
Bezredka method
Bezredka method (A.M. Bezredka, a microbiologist, was born in Russia, worked in France, 1870-1940) - a specific method of desensitization of the body that is used to prevent complications after the administration of heterogeneous serums.
Bezredka method
Heterologous hyperimmune sera (eg, antibotulinum, antitetanus, etc.) are highly concentrated; for desensitization recommended minimum dose. While under the influence of serum antigen occurs, neutralizing antibodies, fixed on the cell surface, and a decline in blood concentrations of physiologically active substances (histamine, etc.) that prevents the development of complications after reintroduction of the antigen.